Literature DB >> 8262526

Chromosomal assignment of the human smg GDP dissociation stimulator gene to human chromosome 4q21-q25.

O Riess1, C Epplen, I Siedlaczck, J T Epplen.   

Abstract

The 3'-end of the cDNA encoding the smg GDP dissociation stimulator (smg GDS) protein shares 100% homology with the previously published expressed sequence tag 00038 site. This site extends the 3'-end of the smg GDS gene by 212 bp. It has been localized to human chromosome 4. Here, we have refined the localization of smg GDP to human chromosome 4q21-q25 using a mapping panel of rodent/human somatic cell hybrids containing different parts of chromosome 4. This chromosomal localization of smg GDP to 4q21-25 overlaps with a region of allele loss in primary hepatocellular carcinoma (4q13-q26).

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8262526     DOI： 10.1007/bf00420952

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


  12 in total

1.  Chromosomal assignment of 38 human brain expressed sequence tags (ESTs) by analyzing fluorescently labeled PCR products from hybrid cell panels.

Authors:  A S Durkin; D R Maglott; W C Nierman
Journal:  Genomics       Date:  1992-11       Impact factor: 5.736

2.  Identification of a nucleotide exchange-promoting activity for p21ras.

Authors:  J Downward; R Riehl; L Wu; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

3.  A stimulatory GDP/GTP exchange protein for smg p21 is active on the post-translationally processed form of c-Ki-ras p21 and rhoA p21.

Authors:  T Mizuno; K Kaibuchi; T Yamamoto; M Kawamura; T Sakoda; H Fujioka; Y Matsuura; Y Takai
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

4.  Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma.

Authors:  K H Buetow; J C Murray; J L Israel; W T London; M Smith; M Kew; V Blanquet; C Brechot; A Redeker; S Govindarajah
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 5.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

6.  A novel membrane factor stimulates guanine nucleotide exchange reaction of ras proteins.

Authors:  M West; H F Kung; T Kamata
Journal:  FEBS Lett       Date:  1990-01-01       Impact factor: 4.124

7.  Purification of a factor capable of stimulating the guanine nucleotide exchange reaction of ras proteins and its effect on ras-related small molecular mass G proteins.

Authors:  Y K Huang; H F Kung; T Kamata
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

8.  A cytosolic protein catalyzes the release of GDP from p21ras.

Authors:  A Wolfman; I G Macara
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

9.  p53: a frequent target for genetic abnormalities in lung cancer.

Authors:  T Takahashi; M M Nau; I Chiba; M J Birrer; R K Rosenberg; M Vinocour; M Levitt; H Pass; A F Gazdar; J D Minna
Journal:  Science       Date:  1989-10-27       Impact factor: 47.728

10.  Molecular cloning of the human cDNA for a stimulatory GDP/GTP exchange protein for c-Ki-ras p21 and smg p21.

Authors:  A Kikuchi; K Kaibuchi; Y Hori; H Nonaka; T Sakoda; M Kawamura; T Mizuno; Y Takai
Journal:  Oncogene       Date:  1992-02       Impact factor: 9.867
View more
  2 in total

Review 1.  Toward the complete genomic map and molecular pathology of human chromosome 4.

Authors:  O Riess; B Winkelmann; J T Epplen
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

2.  Meta-Analysis of Tourette Syndrome and Attention Deficit Hyperactivity Disorder Provides Support for a Shared Genetic Basis.

Authors:  Fotis Tsetsos; Shanmukha S Padmanabhuni; John Alexander; Iordanis Karagiannidis; Margaritis Tsifintaris; Apostolia Topaloudi; Dimitrios Mantzaris; Marianthi Georgitsi; Petros Drineas; Peristera Paschou
Journal:  Front Neurosci       Date:  2016-07-22       Impact factor: 4.677
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.